Latent View Analytics posts 21.6% YoY revenue growth in Q1FY27
Latent View Analytics delivered strong top-line growth in Q1FY27 with revenue rising 21.6% YoY to ₹2,869 million, led by a 110% surge in Financial Services. However, margins compressed as adjusted EBITDA dropped to 20.4% amid cost pressures. The quarter also marked a leadership transition with Sonal Ramrakhiani taking over as CEO.

*this image is generated using AI for illustrative purposes only.
Latent View Analytics reported a 21.6% year-on-year revenue growth to ₹2,869 million for the quarter ended June 30, 2026 (Q1FY27), driven by strong momentum in its Financial Services and Technology, Media & Telecommunications (TMT) practices. The Chennai-based AI-driven analytics firm also announced the appointment of Sonal Ramrakhiani as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP), effective August 01, 2026. While revenue expanded significantly, adjusted EBITDA margins contracted to 20.4% from 24.1% in Q4FY26, primarily due to annual wage hikes effective April 01, 2026, and seasonally higher visa and marketing costs.
The Board of Directors approved Ms. Ramrakhiani’s appointment via a Circular Resolution dated July 15, 2026, following recommendations from the Nomination and Remuneration Committee. This leadership change coincides with the company’s financial results announcement. Rajan Sethuraman, Strategic Advisor to the CEO, welcomed Ms. Ramrakhiani, noting she joins at an "inflection point" for the company. Ms. Ramrakhiani brings over 24 years of experience, including roles at Wipro Engineering Edge and Tata Technologies.
Financial Performance
Consolidated revenue from operations stood at ₹2,869 million in Q1FY27, compared to ₹2,886 million in Q4FY26, representing a slight quarter-on-quarter decline of 0.6%. However, the year-on-year growth was robust at 21.6%. Profit before tax (PBT) was ₹653 million, down 7.7% quarter-on-quarter but up 5.3% year-on-year. Net profit attributable to owners (PAT) decreased to ₹471 million from ₹551 million in the previous quarter, reflecting a 14.5% quarter-on-quarter drop, though it remained positive year-on-year despite a 6.9% decline compared to the same period last year.
| Particulars (₹ Million) | Q1FY27 | Q4FY26 | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Total Operating Revenue | 2,869 | 2,886 | (0.6%) | 21.6% |
| Adjusted EBITDA | 586 | 695 | (15.7%) | 12.0% |
| Adjusted EBITDA % | 20.4% | 24.1% | (3.7%) | (1.7%) |
| EBITDA | 567 | 675 | (16.0%) | 12.5% |
| PBT | 653 | 707 | (7.7%) | 5.3% |
| PAT | 471 | 551 | (14.5%) | (6.9%) |
| Basic EPS (₹) | 2.33 | 2.55 | (8.8%) | (5.5%) |
Segment Growth and AI Adoption
Financial Services practice saw a significant 110% year-on-year growth, offsetting softness in the Consumer Products & Retail (CPGR) segment, which was affected by one-time projects in Q4FY26. The TMT practice grew by 4% year-on-year. AI continues to play a critical role in the company’s operations, impacting 81% of engagements, with 35% of projects focused on delivering AI-driven outcomes. GenAI and multi-agent systems are being utilized for legacy code migration, real-time environment monitoring, and marketing performance analysis.
Governance and Strategic Investments
In addition to the CEO appointment, the Board reconstituted the Corporate Social Responsibility Committee, inducting Independent Director Mr. Reed Cundiff as a member. The company also strengthened its Board with the appointment of senior finance leader Sudha Sankaran. The Advisory Council welcomed Kamal Sharma and Puneet Talwar.
LatentView Analytics Corporation, a wholly owned subsidiary, executed a Simple Agreement for Future Equity (SAFE Notes) investment of INR 279.98 million (USD 3 million) in Healtheon AI INC. on April 01, 2026. Healtheon AI specializes in Agentic-AI frameworks for Revenue Cycle Management services for US healthcare providers. An ongoing dispute regarding the acquisition of the remaining 20% equity interest in Decision Point Private Limited remains unresolved, with management providing for a maximum obligation of INR 708.48 million.
Historical Stock Returns for Latent View Analytics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.85% | +7.59% | +16.77% | -22.33% | -22.99% | -35.30% |
How will the new CEO's leadership strategy address the contraction in adjusted EBITDA margins amidst rising wage and operational costs?
What is the timeline for monetizing the 35% of projects focused on AI-driven outcomes to offset the YoY decline in net profit?
Will the investment in Healtheon AI serve as a template for LatentView's future M&A strategy in the US healthcare sector?


































